Evidence map›Paper›PMID 42292784›Full record

ReviewEndoscopic ultrasound

Efficacy and safety of EUS-guided radiofrequency ablation in pancreatic neuroendocrine tumors: A systematic review and meta-analysis.

Khyati Bidani, Vishali Moond, Prateek S Harne, Hassam Ali, Ruchir Paladiya, Babu P Mohan, Arkady Broder, Nirav Thosani, Douglas G Adler

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Endoscopic ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Khyati BidaniDepartment of Internal Medicine, Saint Peter's University Hospital/Robert Wood Johnson Medical School, New Brunswick, NY, USA.
Vishali MoondDepartment of Internal Medicine, Saint Peter's University Hospital/Robert Wood Johnson Medical School, New Brunswick, NY, USA.
Prateek S HarneCenter for Interventional Gastroenterology at UTHealth (iGUT), McGovern Medical School, Houston, TX, USA.
Hassam AliDepartment of Gastroenterology, Hepatology and Nutrition, ECU Health Medical Center/Brody School of Medicine, Greenville, NC, USA.
Ruchir PaladiyaDepartment of Internal Medicine, University of Connecticut Health Center, Farmington, CT, USA.
Babu P MohanDepartment of Gastroenterology and Hepatology, Orlando Gastroenterology PA, Orlando, FL, USA.
Arkady BroderDivision of Gastroenterology and Hepatology, Saint Peter's University Hospital/Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Nirav ThosaniDepartment of Gastroenterology, Hepatology and Nutrition, ECU Health Medical Center/Brody School of Medicine, Greenville, NC, USA.
Douglas G AdlerCenter for Advanced Therapeutic Endoscopy, Centura Health, Porter Adventist Hospital, Denver, CO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EUS-guided radiofrequency ablation (EUS-RFA) has gained recognition in the last decade as a preferred alternative method for pancreatic neuroendocrine tumors (PNETS) where surgical resection is contraindicated. However, clinical outcomes of EUS-RFA for PNETS have not been well studied due to variability in procedure techniques and lack of data from good-quality studies. In this meta-analysis, we aim to study the pooled clinical outcomes of EUS-RFA in patients with PNETS. We searched multiple electronic databases and conference proceedings from inception through Jan 2024. The clinical outcomes studied were pooled technical success, clinical success, and adverse events. We also performed a subgroup analysis based on the sample size of the studies. Standard meta-analysis methods were employed using the random-effects model, and heterogeneity was studied by

Indexed as

ablation techniquesneuroendocrine tumorspancreatic neoplasmsradiofrequency ablationtreatment outcome

Identifiers

PMID42292784
PMCPMC13263080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.